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Abstract: 
This study was conducted to assess the role of AMPK in regulating meiosis in 
mouse oocytes from the germinal vesicle stage to metaphase II. Exposure of 
mouse cumulus cell-enclosed oocytes (CEO) and denuded oocytes (DO) 
during spontaneous maturation in vitro to AMPK-activating agents resulted in 
augmentation of the rate and frequency of polar body formation. Inhibitors of 
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AMPK had an opposite, inhibitory effect. In addition, the AMPK inhibitor, 
compound C (Cmpd C) increased the frequency of oocyte activation. The 
stimulatory action of the AMPK-activating agent, AICAR, and the inhibitory 
action of Cmpd C were diminished if exposure was delayed, indicating an 
early action of AMPK on polar body formation. The frequency of spontaneous 
and Cmpd C-induced activation in CEO was reduced as the period of hormonal 
priming was increased, and AMPK stimulation eliminated the activation 
response. Immunostaining of oocytes with antibody to active AMPK revealed 
an association of active kinase with chromatin, spindle poles and midbody 
during maturation. Immunolocalization of the α1 catalytic subunit of AMPK 
showed an association with condensed chromatin and the meiotic spindle, but 
not in the spindle poles or midbody; α2 stained only diffusely throughout the 
oocyte. These data suggest that AMPK is involved in a regulatory capacity 
throughout maturation and helps promote the completion of meiosis while 
suppressing premature activation. 
 
INTRODUCTION 
AMP-activated protein kinase (AMPK) is an important cellular 
energy sensor that is activated in response to deficits in ATP and acts 
by shutting down energy consumption and turning on energy-
generating pathways (Hardie, 2003; Carling, 2004). It is a trimeric 
protein comprised of β and γ regulatory subunits and an α catalytic 
subunit and is present in all tissues studied. Two isoforms of the 
catalytic subunit exist, α1 and α2 and both are present in mouse 
oocytes (Downs et al, 2002). Recent studies from our lab have 
demonstrated a role for AMPK in controlling the resumption of meiotic 
maturation in mouse oocytes. AMPK within the oocyte can be activated 
by hormones, stress and adenosine and AMP analogs, and such 
activation precedes, and is a causal force for, meiotic resumption; 
moreover, suppressing AMPK activity blocks meiotic induction brought 
about by these different stimuli (Chen et al, 2006; Downs and Chen, 
2006; LaRosa and Downs, 2006, 2007; Chen and Downs, 2008). 
While AMPK involvement in meiotic resumption is well 
established, much less is known about its participation in meiosis 
following germinal vesicle breakdown (GVB) in mouse oocytes. It was 
therefore the goal of the present study to examine how AMPK might 
contribute to mouse oocyte maturation from GVB to first polar body 
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extrusion. Through the use of stimulators and inhibitors of AMPK, and 
immunofluorescent localization of the kinase, evidence is presented 
that active AMPK associates with condensed chromatin and the meiotic 
spindle and exerts a positive influence on polar body formation, while 
suppressing activation. 
RESULTS 
Effects of AMPK Modulators on polar body formation 
Activators Cumulus cell-enclosed oocytes (CEO) were cultured 16-17 
h in medium containing increasing concentrations of 5-
aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR) or AMP, 
and were assessed for polar body formation. The percentage of CEO 
progressing to MII in control cultures was 50-54%. AICAR stimulated a 
significant increase in PB formation at the lower two doses, but at the 
highest dose was inhibitory, while AMP was stimulatory at all doses 
tested (Fig. 1A). The degree of stimulation was similar (a 26-27% 
increase) within the two groups at the maximally effective 
concentration. 
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Figure 1 Effect of AMPK activation on polar body formation. (A) CEO were cultured 
16-17 h in medium containing increasing concentrations of AICAR or AMP and 
assessed for polar body formation; (B) CEO were cultured for 7-16 h in control 
medium or medium containing 200 μM AICAR and checked every 3 h for polar body 
formation; (C) DO were cultured 9 h in medium containing increasing concentrations 
of AICAR, AMP or 8-Br-Ado and assessed for polar body formation; (D) DO were 
cultured 8-14 h in control medium or medium containing 100 μm AICAR and assessed 
every 2 h for polar body formation; (E) DO were pulsed 3 h in medium lacking 
pyruvate and glucose or in medium containing 10 mM 2-D-Glc, or they were 
continuously cultured in control medium or medium lacking pyruvate and glucose. 
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After a total culture time of 9 h, oocytes were assessed for polar body formation. A 
different letter at the top of the bar denotes a significant difference. 
The action of AICAR on the kinetics of PB formation was next 
tested. CEO were cultured 7, 10, 13 or 16 h in control medium or 
medium containing 200 μM AICAR. In control cultures, PB formation 
was initiated between 7 and 10 h of culture, with 28% of the oocytes 
reaching metaphase II (MII) at 10 h and 62.5% by 17 h (Fig. 1B). The 
frequency of PB formation in AICAR-treated oocytes was already 64% 
after 10 h and this number peaked 6 h later at 78%. It is clear from 
these data that AICAR stimulated both the rate and frequency of PB 
formation. When CEO were cultured in 2 mM AMP, a comparable 
increase in PB formation was observed at 10 h (average of 62% MII in 
AMP-treated oocytes compared to 27% in controls; n = 3). 
To determine if these agents act directly on the oocyte, similar 
experiments were conducted with denuded oocytes (DO). An AICAR 
dose response experiment first determined the most effective 
concentration. Since preliminary experiments showed a higher PB 
percentage in DO than CEO when cultured in control medium for 16-17 
h (≥ 90%), the culture period for this experiment was shortened to 9 
h. As shown in Fig. 1C, the effective dose for AICAR peaked at 100 μM, 
with an increase in PB formation from 39% to 90%, and the highest 
dose tested (500 μM) proved to be detrimental to development (22% 
at MII). When 100 μM AICAR was then tested on the kinetics of PB 
formation, the frequency of PB formation in DO was increased by this 
agent at all time points (Fig. 1D), demonstrating a direct, stimulatory 
action on the oocyte. 
To test whether other AMPK-activating agents can also promote 
PB formation in DO, a dose response experiment with AMP was carried 
out with DO cultured for 9 h. However, at the effective concentrations 
used for CEO, AMP had no significant effect on PB formation (Fig. 1C). 
Another AMPK activator, 8-Br-adenosine (8-Br-Ado), that has 
previously been shown to augment PB formation in CEO (Downs and 
Chen, 2006), was next tested. A response curve similar to that 
obtained with AICAR was observed, with the peak concentration (200 
μM) increasing the PB rate by 27% (Fig. 1C). 
Exposing mouse oocytes to different stresses stimulates meiotic 
resumption in an AMPK-dependent manner (Larosa and Downs, 2006, 
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2007). Initial experiments in which oocytes were heat stressed at 42°C 
for 30-60 min produced no beneficial effect on progression to MII. 
Thus, an alternative approach was utilized that stressed the oocyte at 
the level of energy metabolism. In a previous study, it was shown that 
the TCA cycle inhibitor, arsenite, promoted AMPK and GVB in arrested 
oocytes (LaRosa and Downs, 2007). However, it was important for the 
oocyte to recover from the stress and be capable of generating energy 
after the stress pulse, since maturation is an active, energy-requiring 
process (Downs et al, 2007). Thus, 2-deoxy-glucose (2-D-Glc) to 
achieve ATP depletion in DO. This agent depletes ATP by the action of 
hexokinase, since the product, 6-phospho-2-D-Glc, cannot be used in 
glycolysis to generate more ATP. Three test conditions were evaluated: 
(1) 3-h pulse with glucose- and pyruvate-free medium; (2) 3-h pulse 
with this same medium containing 10 mM 2-D-Glc; and (3) continuous 
exposure to 2-D-Glc in the absence of glucose and pyruvate. Total 
culture time for all groups was 9 h. As shown in Fig. 1E, pulsing in the 
presence, but not absence, of 2-D-Glc stimulated PB formation, 
whereas continuous exposure to 2-D-Glc had no effect on GVB but 
eliminated meiotic progression to MII. 
Inhibitors If AMPK promotes PB formation, then suppressing its 
activity should have the opposite effect. Indeed, when CEO were 
cultured 16-17 h with the AMPK inhibitors, compound C (Zhou et al, 
2001) and araA (Henin et al, 1996), suppression of meiotic 
progression was observed. Both inhibitors blocked PB formation in 
dose-dependent fashion, with Cmpd C the more effective agent (Fig. 
2A). The highest dose of Cmpd C reduced PB formation by 44%, while 
this number was decreased 24% by araA treatment. Interestingly, 
Cmpd C, but not araA, stimulated oocyte activation, such that at a 
concentration of 2.5 μm, 19% of the oocytes were activated compared 
to 0% of controls. These oocytes displayed a prominent polar body 
and pronucleus and, upon overnight culture in control medium, most 
underwent some form of cleavage, though few normal two-cell stages 
were observed. Rather, most of the eggs exhibited unequal cleavage 
with differing degrees of cytoplasmic blebbing. 
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Figure 2 Effect of AMPK inhibition on polar body formation. CEO (A) or DO (B) 
were cultured for 16-17 h in medium containing increasing concentrations of 
Compound C or araA and assessed for polar body formation or activation. Inhibitor 
concentrations: 1, 2.5 and 5 μM Cmpd C; 1, 1.5 and 2 mM araA. 
When the effect of these agents was tested on DO, Cmpd C 
demonstrated a similar potency in suppressing PB formation, while the 
effect of araA was less pronounced (Fig. 2B). Less activation was 
observed in Cmpd C-treated DO when compared to similarly treated 
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CEO, appearing only in the 2.5 μM group (9.8% activated), while no 
activation was observed in araA-treated DO. 
Effect of Timing the Exposure to AICAR and Cmpd C on 
PB Formation and Activation 
To determine when in the culture period oocytes were sensitive 
to AICAR and Cmpd C treatment, CEO were cultured for 16-17 h and 
exposure to these agents was delayed for 0, 2 or 4 h. As shown in Fig. 
3, delaying AICAR exposure reduced the stimulation of PB formation, 
suggesting an early effect of AMPK on this developmental endpoint. 
Consistent with this finding was the progressive loss of inhibition by 
Cmpd C of PB formation with later administration, such that when 
delayed 4 h, the percentage of MII oocytes was not significantly 
different than controls (43% versus 54%). This demonstrates that the 
action of Cmpd C is not due to a general toxic effect. However, the 
percentage of activated oocytes was similar (12-17%) regardless of 
when Cmpd C exposure took place, suggesting a later, protective 
action of AMPK on activation. 
       
Figure 3 Effect of timing of exposure to AICAR and Cmpd C on polar body 
formation and activation. CEO were cultured 16-17 h and were exposed to 200 μM 
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AICAR or 2.5 μM Cmpd C at 0, 2 or 4 h after the onset of culture and then assessed 
for polar body formation and activation. 
Effects of PMSG Priming on Polar Body Formation and 
Oocyte Activation 
In a previous study (Downs, 1990), oocytes from mice primed 
only 1 d had a significantly higher percentage of activation during 
spontaneous maturation than oocytes from mice primed 2 days. This 
finding was exploited to further analyze the effects of AMPK on PB 
formation and activation. CEO from unprimed mice and from mice 
primed for 1 d or 2 d were cultured for 21-22 h in control medium or 
medium containing either 200 μM AICAR or 2.5 μm Cmpd C and then 
assessed for PB formation and activation. The culture time was 
extended in these experiments, because longer culture times were 
shown to augment the effect on activation (Downs, 1990). These data 
are presented in Figure 4A. Control oocytes from 1-d- and 2-d-primed 
mice displayed identical percentages at MII (62%), with this value 
reduced in oocytes from unprimed mice (47%). In all three groups, 
AICAR treatment significantly stimulated PB formation (by 21-22% in 
oocytes from primed animals and 46% in oocytes from unprimed 
animals). As the period of priming increased, the degree of 
spontaneous activation decreased (10%, 6% and 1%, respectively, in 
2-d-primed, 1-d-primed and unprimed mice) as well as the extent of 
Cmpd-C-stimulated activation (47%, 38% and 19%, respectively). 
Moreover, spontaneous activation was completely eliminated by AICAR 
treatment in all groups. These results support the idea that activation 
of AMPK promotes meiotic progression to MII while, at the same time, 
suppressing spontaneous activation of the oocyte. In addition, priming 
mice with eCG protects the oocytes from activation during 
spontaneous maturation in culture. 
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Figure 4 Effect of priming on polar body formation and oocyte activation. (A) CEO 
were derived from unprimed mice or mice primed for 1 or 2 d, cultured 21-22 h in 
control medium or medium containing 200 μM AICAR or 2.5 μM Cmpd C, and assessed 
for polar body formation and activation; (B) CEO from 1-d-primed mice were cultured 
15-24 h in either the absence (−) or presence (+) of 2.5 μM Cmpd C and assessed 
every 3 h for polar body formation (PB) and activation (Act). 
A kinetics experiment was carried out to determine the timing of 
oocyte activation as it relates to PB formation. CEO from 1-d-primed 
mice were cultured for varying periods of time from 15 h to 24 h in the 
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presence or absence of 2.5 μM Cmpd C and assessed for PB formation 
and activation. In control oocytes, the percentage of oocytes at MII 
peaked at 18 h (55%) and then declined to 35% at 24 h (Fig. 4B). A 
similar pattern was observed in Cmpd C-treated oocytes, but at 
reduced rates, with PB frequency peaking at 26% and decreasing 6 h 
later to 9%. In control oocytes, activation was initiated between 18 
and 21 h of culture, at the same time PB frequency started to 
decrease. The percentage of activated oocytes at 24 h (17%) was 
similar to the 20% decrease in MII oocytes at this time. Activation in 
Cmpd C-treated oocytes was initiated as early as 15 h (5%) and 
increased rapidly thereafter, to 48% at 24 h. These data suggest that 
a significant portion of the activated oocytes derived from MII-stage 
oocytes. 
In a separate experiment (n = 6), CEO from 1-d-primed mice 
were cultured 21-22 h in MEM/BSA ± 2 mM AMP to determine if this 
agent could also prevent spontaneous oocyte activation. In the 
absence of AMP, 15.2 ± 3.5% of the CEO (42 out of 273) underwent 
activation, as noted by the presence of a second PB and pronucleus. 
AMP significantly suppressed the activation response, as only 2.5 ± 
1.2% of the CEO (8 total out of 273) had responded in this manner. 
Immunostaining of Active AMPK Throughout Meiotic 
Maturation 
Oocytes were fixed at different stages of meiotic maturation and 
then stained for active AMPK using an antibody that recognizes 
phospho-threonine 172 on the catalytic subunit of the kinase. Four 
different maturation conditions were utilized for these experiments: 
(1) in vivo maturation following hCG injection to primed animals: (2) 
spontaneous maturation of CEO; and meiotic induction in (3) dbcAMP-
arrested DO stimulated with AICAR and (4) dbcAMP-arrested CEO 
stimulated with FSH. Oocytes were examined at the following meiotic 
stages: GVB, metaphase I (MI), anaphase and metaphase II (MII). 
Maturation in vivo In oocytes undergoing maturation in vivo in 
response to hCG stimulation, active AMPK became associated with the 
condensed chromosomes immediately after GVB (Fig. 5). Active AMPK 
then began to move to two regions at opposite ends of the chromatin 
mass, and, at MI, staining was prominently positioned at the spindle 
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poles. During chromosome segregation, however, staining at the poles 
disappeared and intense staining appeared in the midbody region. 
After polar body formation, intense staining was often seen throughout 
the polar body, but only in oocytes that had recently completed 
anaphase. As the MII spindle was established, staining in the PB 
disappeared and again became prominent at the spindle poles. 
Specificity for active AMPK was demonstrated in MI-stage oocytes by 
the disappearance of staining at the spindle poles when primary 
antibody was omitted or when primary antibody was preincubated with 
blocking peptide specific for the PT172 epitope (Fig. 5). 
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Figure 5 Immunolocalization of active AMPK throughout oocyte maturation. 
Oocytes were isolated at varying stages of meiosis after hCG administration to 2-d-
primed mice, fixed and stained with anti-PT172 antibody for active AMPK (green) and 
DAPI for chromatin (blue). Controls in the bottom row were of MI-stage oocytes and 
were either not exposed to primary antibody or anti-PT172 antibody was first treated 
with blocking peptide. GVB, germinal vesicle breakdown; MI, metaphase I, Ana, 
anaphase, MII, metaphase II. 
Maturation in vitro When immuofluorescence for active AMPK was 
examined throughout maturation in the different in vitro model 
systems, localization in all three groups was identical to that observed 
in oocytes maturing in vivo (Supplementary Fig. 1). Thus, the 
temporal pattern of active AMPK distribution was consistent at the 
different stages of maturation regardless of whether maturation 
occurred spontaneously, was induced in vivo by hCG, or was induced 
in vitro by AICAR or FSH. 
Immunostaining of isoforms of the catalytic subunit of 
AMPK 
Since there are two different isoforms of the catalytic alpha 
subunit of AMPK, we examined the distribution pattern of each isoform 
using isoform-specific antibodies. A light diffuse staining of alpha 2 
was manifest throughout maturation with no discrete localization 
associated with chromosomes or meiotic apparatus (not shown). On 
the other hand, alpha 1 showed intense colocalization with condensed 
chromosomes following GVB, was associated with MI and MII spindle 
MTs, and colocalized with migrating chromosomes during anaphase 
(Fig. 6). This stain was eliminated when primary antibody was omitted 
or when primary antibody was pretreated with blocking peptide for 
alpha 1. Blocking peptide for alpha 2 had no effect on alpha 1 staining. 
These results are interesting in that, similar to that for active AMPK, 
alpha 1 staining was associated with chromosomes and the meiotic 
spindle, but the precise localization after spindle formation did not 
coincide with that of the active kinase. 
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Figure 6 Immunolocalization of the α1 catalytic subunit of AMPK. Oocytes were 
fixed at varying stages of meiosis following hCG injection to 2-d-primed mice and 
stained for with anti-α1 antibody (green) and with DAPI for chromatin (blue). Controls 
in the bottom row were of MI-stage oocytes and were either not exposed to primary 
antibody or anti-α1 antibody was first treated with α1 blocking peptide or α2 blocking 
peptide. GVB, germinal vesicle breakdown; MI, metaphase I; Ana, anaphase; MII, 
metaphase II. 
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DISCUSSION 
Evidence is presented that activation of AMPK in the mouse 
oocyte promotes the completion of meiotic maturation and suppresses 
activation, while inhibition of this kinase has the opposite results. AMP 
and AICAR each stimulated an increase in both the rate and frequency 
of polar body formation in spontaneously maturing oocytes. On the 
other hand, Cmpd C and araA both blocked polar body formation, and 
Cmpd C promoted activation. Susceptibility of oocytes to activation 
was indirectly related to the extent of eCG priming; moreover, AICAR 
and AMP prevented activation, while Cmpd C augmented activation. 
Immunolocalization of active AMPK revealed an initial association with 
condensed chromosomes after GVB and with the meiotic apparatus 
thereafter, supporting a meiotic regulatory role throughout the entire 
period of oocyte maturation. 
Previous work has shown that AMPK activation precedes GVB in 
mouse oocytes and is a causal force behind meiotic resumption (Chen 
et al, 2006). The present study was conducted to determine if, after 
GVB, AMPK continues to participate in the mechanisms regulating the 
progression of meiosis to MII. Several lines of evidence presented 
herein indicate an important role for AMPK throughout the maturation 
period. Both AICAR and AMP dose-dependently increased the extent, 
and accelerated the kinetics of, PB formation in spontaneously 
maturing CEO, while treatment with AMPK inhibitors produced the 
opposite effect. Furthermore, stressing the oocyte by depleting ATP 
with 2-deoxyglucose treatment also promoted the completion of 
maturation. Such treatment increases the AMP/ATP ratio and 
stimulates AMPK and is often used in somatic cells to activate the 
kinase (eg, Hurley et al, 2005; Zhu et al, 2005; Park et al, 2009; 
Fujimoto et al, 2010; Pradelli et al, 2010). The response to 2-DG 
pulsing is therefore consistent with the effects of AICAR and AMP. It 
should be noted that the frequency of MII-stage control oocytes, 
consistently maintained throughout the study at ~50-62%, was lower 
than that reported in an earlier study utilizing similar culture 
conditions (Downs and Hudson, 2000). While the reason for this 
difference is not known, it is not due simply to suboptimal culture 
conditions, since CEO from unprimed mice and DO from primed mice 
reached MII at very high levels (~90%) and AMPK activation increased 
both the extent and kinetics of PB formation. 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Molecular Reproduction and Development, Vol. 77, No. 10 (October 2010): pg. 888-899. DOI. This article is © Wiley and 
permission has been granted for this version to appear in e-Publications@Marquette. Wiley does not grant permission 
for this article to be further copied/distributed or hosted elsewhere without the express permission from Wiley. 
16 
 
Because a higher number of DO than CEO progressed to the MII 
stage after 16-17 h of culture, shorter time points were utilized to 
assess the effects of AMPK modulators on PB formation in DO. While 
AICAR increased the incidence of PB formation in DO after 9 h of 
culture by over 50%, AMP curiously had no effect. An additional 
activator of AMPK, 8-Br-Ado (Downs and Chen, 2008), produced a 
29% increase in PB frequency. The reason for the failure of AMP to 
affect maturation in DO is not known, but it is possible that uptake by 
the oocyte may be hampered by removal of the cumulus cells. A 
similar discrepancy in efficacy between DO and CEO was observed with 
araA. Like Cmpd C, this inhibitor effectively suppressed PB formation 
in CEO; however, while Cmpd C was similarly effective in DO, araA 
displayed a much reduced inhibitory potency. Nevertheless, taken 
together these data strongly suggest that AMPK plays an important 
maturation-promoting role throughout the period from GVB to MII. It 
will be important to determine how the somatic compartment 
contributes to this regulation. 
Additional support for AMPK involvement in the completion of 
meiotic maturation was provided by the stimulation of oocyte 
activation by Cmpd C during overnight culture. This is not 
unprecedented, since other protein kinase inhibitors have been shown 
to promote this developmental response. For example, a wide range of 
studies have shown that the general kinase inhibitor, 6-
dimethylaminopurine, is an effective inducer of parthenogenesis in 
oocytes of many mammalian species, including mouse (Szllosi et al, 
1993; Liu et al, 1997; Nakasaka et al, 2000), rat (Jiang et al, 2002; 
Sano et al, 2009), cat (Yin et al, 2007), rabbit (Liu et al, 2002), pig 
(Leal and Liu, 1998; Jilek et al, 2001), bovine (Winger et al, 1997; Liu 
et al, 1998), sheep (Loi et al, 1998; Choi et al, 2004; Alexander et al, 
2006), goat (Ongeri and Krisher, 2001), camel (Wani, 2008), rhesus 
monkey (Mitalipov et al, 2001) and human (Nakagawa et al, 2001). 
This is due in large measure to interruption of maturation promoting 
factor (MPF) activity, which is required to maintain MII arrest and is 
regulated by mitogen-activated protein kinase (Fan and Sun, 2004). 
Accordingly, inhibitors of the upstream kinase, MEK, also trigger 
activation (Tong et al, 2003). Data herein suggest that blocking AMPK 
activity in mouse oocytes interferes with this MII meiotic control point 
and leads to activation, perhaps through suppression of ERK1/2 
activity, though it should be noted that Cmpd C had no effect on 
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ERK1/2 phosphorylation in bovine oocytes (Tosca et al, 2007). The 
fact that CEO were more susceptible to activation than DO is 
consistent with studies showing that cumulus cells promote activation 
in aging mouse oocytes (Miao et al, 2005) 
When the administration of AICAR was delayed after the onset 
of culture by 2 or 4 h, there was a progressive reduction in the 
stimulation of PB formation in CEO, suggesting that the increase in PB 
number requires early exposure to active AMPK. This is consistent with 
the finding that a similar delay in exposure to Cmpd C significantly 
reduces its inhibitory activity on PB formation. However, a more 
protracted period of susceptibility exists for Cmpd C-induced 
activation, since comparable levels of activation were observed 
whether exposure to this inhibitor occurred 0, 2 or 4 h after the onset 
of culture. It therefore appears that sustained AMPK activity during a 
substantial portion of the maturation period is important to maintain a 
normal course of maturation and suppress oocyte activation. 
In an earlier study, oocytes from 1-d-primed mice were more 
susceptible to activation during spontaneous maturation than those 
from mice primed 2 d (Downs, 1990). This observation was expanded 
upon to further evaluate the role of AMPK in oocyte activation by 
comparing oocytes from unprimed mice with those from mice primed 1 
or 2 d. While less than 1% of spontaneously maturing CEO from 2-d-
primed mice became activated during 17-18 h of culture, 6 or 10% 
were activated in CEO from 1-d-primed or unprimed mice, 
respectively. That this phenomenon was sensitive to regulation by 
AMPK was supported by the observation that treatment with AICAR or 
AMP suppressed oocyte activation, while Cmpd C appreciably 
augmented the activation rate, most notably in the unprimed group, 
where an increase from 10% to 47% was observed. 
The dynamics of oocyte activation received further scrutiny in 
the kinetics experiment that utilized oocytes from 1-d-primed mice, 
where extending the culture time to 24 h revealed an even greater 
activation response in both the absence and presence of Cmpd C. This 
stems from the fact that prolonged culture lessens the ability of 
oocytes to maintain MPF activity, making them more susceptible to 
spontaneous and induced activation (Fissore et al, 2002). PB formation 
peaked at 18 h and declined thereafter, in concert with a 
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corresponding increase in activation frequency, suggesting that a 
significant portion of the activated eggs originated from MII-stage 
oocytes. Indeed, the 20% decrease in MII-stage oocytes in the control 
group between 18 h and 24 h coincides closely with the 17% increase 
in activation. However, we cannot discount the possibility that some 
activated oocytes derive from MI-stage oocytes without transit through 
MII, as has been reported in LT/Sv and LTXBO mouse strains whose 
oocytes display high spontaneous activation rates (Kaufman and 
Howlett, 1986; Maleszewski and Yanagimachi, 1995; Eppig et al, 1996, 
2000). It will be interesting to determine whether AMPK activity 
influences parthenogenetic activation brought about by a number of 
different chemical treatments (cf, Kaufman, 1983). 
In previous double immunofluorescent staining experiments 
using an anti-phospho-threonine 172 antibody that targets the 
phosphorylated, active α subunit of AMPK, positive staining was shown 
in the GV of mouse oocytes prior to meiotic resumption and later 
colocalized with condensed chromatin following GVB (Chen et al, 
2008). This was consistent with a causal role for AMPK in meiotic 
resumption and suggested further involvement in subsequent stages of 
meiosis. Regardless of the conditions of meiotic maturation--whether 
spontaneous, in situ induction via hCG injection, or in vitro induction 
by AICAR or FSH treatment--immunofluorescent staining with the anti-
PT172 antibody revealed a reproducible pattern of localization after 
GVB which further supported the participation of AMPK throughout the 
entire maturation period. Active kinase appeared initially in condensed 
chromosomes, became focused at the spindle poles at MI, shifted to 
the midbody/cleavage furrow region during anaphase I, and then 
reappeared at the spindle poles at MII. 
This pattern of localization for active AMPK throughout 
maturation, notably its association with the meiotic spindle, closely 
resembles that found in oocytes for a number of other kinases, 
including MEK1/2 (Sun et al, 2008), phospho-protein kinase C δ (Ma et 
al, 2008), aurora kinase (Yao and Sun, 2005; Shuda et al, 2009) and 
polo-like kinase (Wianny et al, 1998; Pahlavan et al, 2000; Tong et al, 
2002; Fan et al, 2003). These kinases have all been shown to play a 
vital role in meiotic maturation, particularly in relation to spindle 
dynamics. The localization pattern for active AMPK in the mouse 
oocyte is also identical to that recently described in dividing human 
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cancer cells, mouse NIH-3T3 fibroblasts and 3T3-L1 mouse pre-
adipocytes (Vazquez-Martin et al, 2009). These observations suggest 
an important role for AMPK in cell cycle regulation. 
Indeed, results of a recent genome-wide survey of protein 
kinases revealed a direct link between energy sensing by AMPK and 
cell cycle progression (Bettencourt-Dias et al, 2004). This relationship 
was demonstrated in a study by Jones et al (2005) in which restricting 
glucose availability to mouse primary mouse embryonic fibroblasts 
activated AMPK and, subsequently, a p53-dependent metabolic 
checkpoint; similarly, cells expressing a constitutively active α2 AMPK 
catalytic subunit had impaired proliferative ability. This finding is 
consistent with a recent series of reports demonstrating cessation of 
cell growth and proliferation by AMPK stimulation in a variety of cell 
types (eg, Imamura et al, 2001; Igata et al, 2005; Motoshima et al, 
2006; Baumann et al, 2007; Gwinn et al, 2008; Fogarty and Hardie, 
2009; Ishii et al, 2009; Zang et al, 2009). Further evidence stems 
from the finding that mutations in the upstream AMPK kinase, LKB1 
(Kyriakis, 2003), are responsible for Peutz-Jeghers syndrome, an 
autosomal dominantly inherited cancer in humans (Hemminki et al, 
1998; Jenne et al, 1998). LKB1 is also involved in regulation of cell 
polarity through its action on AMPK (Alessi et al, 2006; Lee et al, 
2007; Mirouse et al, 2007), and in mouse oocytes is present in the 
germinal vesicle and is associated with the meiotic spindle, though it is 
excluded from the polar microtubules and midbody (Szczepanska and 
Maleszewski, 2005). 
Consistent with above observations in somatic cells are the 
findings that AMPK activation suppresses GVB in pigs (Mayes et al, 
2007), cows (Tosca et al, 2007; Bilodeau-Goeseels et al, 2007)) and 
nemertean worms (Stricker et al, 2010). However, mouse oocytes are 
unique in that AMPK activation does not suppress, but, rather, 
promotes cell cycle progression such that arrested GV-stage oocytes 
are stimulated to reinitiate meiotic maturation (Chen et al, 2006), and 
polar body formation in maturing oocytes is increased (data herein). 
The effect of glucose concentrations on cell cycle regulation in mouse 
oocytes likewise differs substantially from that in somatic cells. 
Whereas in somatic cells lower glucose levels block cell proliferation, in 
mouse oocytes it has the opposite effect. In the presence of meiotic 
inhibitors, the G2/M transition is suppressed by increased glucose 
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concentration, while lower glucose levels promote maturation (Downs 
and Mastropolo, 1994; Downs, 1995). This may be related to the fact 
that, unlike in somatic cells, glucose is not a primary energy source for 
oocytes; rather, this role is taken by downstream metabolites of 
glucose, such as pyruvate, that are supplied by the somatic 
compartment of the follicle. Thus, meiotic inhibitors have a poor ability 
to maintain meiotic arrest in mouse oocytes when pyruvate levels are 
high and glucose levels are low, whereas the opposite is true when 
pyruvate is low and glucose is high. Though not yet specifically 
investigated, it is likely that the meiotic response of mouse oocytes to 
these differing energy substrate conditions is closely related to the 
activation status of AMPK. For example, glucose-derived ATP in the 
cumulus cells could transit gap junctions to reach the oocyte (Downs, 
1995), lower the AMP/ATP ratio and maintain AMPK in an inactive 
state. 
Since both type 1 and 2 α subunits for AMPK are present in the 
mouse oocyte (Downs et al, 2002), it was of interest to determine the 
localization pattern for each throughout maturation. The pattern for α2 
was unremarkable, exhibiting a faint diffuse staining throughout the 
maturation period without any localized accumulation. On the other 
hand, staining for α1 showed an intense localization pattern associated 
initially with the condensed chromosomes and later with the meiotic 
spindle. Staining for this subunit also increased in the germinal vesicle 
prior to GVB, which was surprising based on reports that α2, but not 
α1, localizes to the nucleus in somatic cells (Salt et al, 1998). 
Curiously, α1 stained intensely within the spindle proper at both 
metaphase stages and colocalized with migrating chromosomes at 
anaphase, a pattern inconsistent with that observed for the active 
kinase. However, previous studies in somatic cells have failed to 
demonstrate a link between the phosphorylation state of threonine 172 
of AMPK and subcellular localization of the α subunit of AMPK (Kohida 
et al, 2007; Vazquez-Martin et al, 2009). These results suggest that 
α1, and not α2, is the catalytic subunit most important for regulating 
the maturation of mouse oocytes. 
In conclusion, results indicate that AMPK plays an important 
regulatory role in the completion of meiotic maturation in mouse 
oocytes. They also suggest that compromising AMPK activity during 
meiosis has detrimental downstream effects on developmental 
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potential, since although most activated oocytes from Cmpd C-treated 
CEO exhibited some form of mitotic division, cleavages were clearly 
abnormal, often accompanied by extensive blebbing. It will be of 
interest to determine how AMPK affects preimplantation embryonic 
development to see whether AMPK reverts to a suppressive influence 
on cell cycle progression, as has been previously demonstrated in 
mitotic cells. 
MATERIALS AND METHODS 
Oocyte Isolation and Culture Conditions 
Animals were raised in the research colony of the principal 
investigator (SMD). All experiments were carried out with prior 
approval of the Marquette University Institutional Animal Care and Use 
Committee. 
Immature, 19-23-day-old (C57B/6J X SJL/J) F1 mice were used 
for all experiments. In most experiments, mice were primed with 5 IU 
equine chorionic gonadotropin (eCG) and 2 days later were killed; the 
ovaries were removed and placed in culture medium where cumulus 
cell-enclosed oocytes (CEO) were released from the preovulatory 
follicles when poked with sterile needles. Some experiments utilized 
unprimed mice or mice primed only 1 d. Denuded oocytes (DO) were 
obtained by passage of CEO through mouth-operated small bore 
pipets. Oocytes were washed free of other follicular tissue and 
transferred to plastic tubes containing 1 ml of the appropriate test 
medium. The culture medium used was Eagle’s minimum essential 
medium with Earle’s salts (GIBCO/Invitrogen; Carlsbad, CA) 
supplemented with 0.23 mM pyruvate, penicillin, streptomycin sulfate 
and 3 mg/ml crystallized lyophilized bovine serum albumin (ICN 
ImmunoBiologicals, Lisle, IL) and buffered with 26 mM bicarbonate. 
Immunofluorescent Staining 
Oocytes were fixed with 4% formaldehyde at 4°C and 
permeabilized with 0.1% triton in blocking buffer (0.05% saponin in 
PBS, pH 7.4, plus 10% sheep serum) for 30 min. Oocytes were then 
washed free of triton and continuously blocked for another 90 min at 
room temperature. Oocytes were incubated with rabbit primary 
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antibodies (1:100) overnight at 4°C, washed in blocking buffer at 
room temperature, and incubated with FITC-conjugated sheep anti-
rabbit antibody (1:1000) at room temperature for 1 h. For 
experiments involving blocking peptide, primary antibodies were 
incubated for 1 h at room temp with blocking peptide before adding 
oocytes for overnight incubation. After washing, oocytes were 
mounted on pre-washed slides with vectashield mounting medium 
containing DAPI (Vector laboratories, Inc., Burlingame, CA), and cover 
slips were sealed with nail polish. 
Confocal Microscopy 
Oocytes were viewed on a laser scanning confocal microscope 
(Carl Zeiss Co.) with a 63X objective. During imaging all settings were 
kept constant, i.e., laser power, detector gain, amplifier offset, 
amplifier gain and pinhole size. Digitally recorded images were 
exported by LSM Examiner (Carl Zeiss Co.). 
Chemicals 
Saponin, dbcAMP, 8-Br-adenosine, adenine-9-β–D-
arabinofuranoside (araA), sheep serum, and FITC-labeled sheep anti-
rabbit antibody were purchased from Sigma Chemical Co. (St. Louis, 
MO). Compound C and AICAR were supplied by Toronto Research 
Chemicals, Inc. (North York, Ontario). Anti-PT172 antibody was from 
Cell Signaling Technology (Beverly, MA), and anti-PT172, anti-α1 and 
anti-α2 blocking peptides were obtained from Santa Cruz Biotech, Inc. 
(Santa Cruz, CA). Highly purified ovine FSH was purchased from the 
National Hormone and Peptide Program (NHPP), NIDDK, and Dr. AF 
Parlow. 
Statistical Analysis 
Oocyte maturation experiments were repeated at least three 
times with at least 30 oocytes per group per experiment. Data are 
reported as mean percentage GVB±SEM. Following arcsin 
transformation, maturation frequencies were analyzed stastically by 
ANOVA followed by Duncan’s multiple range test. For all statistical 
analyses, a P value less than 0.05 was considered significant. 
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Supplementary Material 
Suppl Figure 1 
Supplemental Figure 1. Immunolocalization of active AMPK 
throughout maturation. Oocytes were fixed at varying stages of 
meiosis using three different in vitro model systems: (1) spontaneous 
maturation of CEO; (2) dbcAMP-arrested CEO stimulated with FSH; 
and (3) dbcAMP-arrested DO stimulated with AICAR. Oocytes were 
fixed and stained with anti-PT172 antibody for active AMPK (green) 
and with DAPI for chromatin (blue). GVB, germinal vesicle breakdown; 
MI, metaphase I; Ana, anaphase: MII, metaphase II. 
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